Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell (vol 18, pg 1004, 2017)

被引：0

作者：

Gao, Yulong

Souza-Fonseca-Guimaraes, Fernando

Bald, Tobias

Ng, Susanna S.

Young, Arabella

Ngiow, Shin Foong

Rautela, Jai

Straube, Jasmin

Waddell, Nic

Blake, Stephen J.

Yan, Juming

Bartholin, Laurent

Lee, Jason S.

Vivier, Eric

Takeda, Kazuyoshi

Messaoudene, Meriem

Zitvogel, Laurence

Teng, Michele W. L.

Belz, Gabrielle T.

Engwerda, Christian R.

Huntington, Nicholas D.

Nakamura, Kyohei

Hoelzel, Michael

Smyth, Mark J.

机构：

[1] QIMR Berghofer Medical Research Institute,Immunology in Cancer and Infection

[2] The University of Queensland,School of Medicine

[3] Department of Medical Biology and The University of Melbourne,Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research

[4] The University of Melbourne,Faculty of Medicine, Dentistry and Health Sciences

[5] QIMR Berghofer Medical Research Institute,Immunology and Infection

[6] Griffith University,School of Natural Sciences

[7] QIMR Berghofer Medical Research Institute,Medical Genomics

[8] QIMR Berghofer Medical Research Institute,Cancer Immunoregulation and Immunotherapy

[9] Centre de recherche en cancérologie de Lyon,Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard

[10] QIMR Berghofer Medical Research Institute,Control of Gene Expression Laboratory

[11] CNRS,Centre d’Immunologie de Marseille

[12] Juntendo University,Luminy, Aix Marseille Université, INSERM

[13] Gustave Roussy Cancer Campus,Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine

[14] Gustave Roussy Cancer Campus,INSERM U1015

[15] Kremlin Bicêtre,University Paris

[16] Gustave Roussy Cancer Campus,Saclay

[17] University of Bonn,CIC1428

来源：

NATURE IMMUNOLOGY | 2024年 / 25卷 / 04期

关键词：

D O I：

10.1038/s41590-024-01799-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：590 / 591

页数：2

共 50 条

[1] Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao
Fernando Souza-Fonseca-Guimaraes
Tobias Bald
Susanna S Ng
Arabella Young
Shin Foong Ngiow
Jai Rautela
Jasmin Straube
Nic Waddell
Stephen J Blake
Juming Yan
Laurent Bartholin
Jason S Lee
Eric Vivier
Kazuyoshi Takeda
Meriem Messaoudene
Laurence Zitvogel
Michele W L Teng
Gabrielle T Belz
Christian R Engwerda
Nicholas D Huntington
Kyohei Nakamura
Michael Hölzel
Mark J Smyth
Nature Immunology, 2017, 18 : 1004 - 1015
[2] Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Gao, Yulong
Souza-Fonseca-Guimaraes, Fernando
Bald, Tobias
Ng, Susanna S.
Young, Arabella
Ngiow, Shin Foong
Rautela, Jai
Straube, Jasmin
Waddell, Nic
Blake, Stephen J.
Yan, Juming
Bartholin, Laurent
Lee, Jason S.
Vivier, Eric
Takeda, Kazuyoshi
Messaoudene, Meriem
Zitvogel-, Laurence
Teng, Michele W. L.
Belz, Gabrielle T.
Engwerda, Christian R.
Huntington, Nicholas D.
Nakamura, Kyohei
Hoelzel, Michael
Smyth, Mark J.
NATURE IMMUNOLOGY, 2017, 18 (09) : 1004 - +
[3] Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell
Yulong Gao
Fernando Souza-Fonseca-Guimaraes
Tobias Bald
Susanna S. Ng
Arabella Young
Shin Foong Ngiow
Jai Rautela
Jasmin Straube
Nic Waddell
Stephen J. Blake
Juming Yan
Laurent Bartholin
Jason S. Lee
Eric Vivier
Kazuyoshi Takeda
Meriem Messaoudene
Laurence Zitvogel
Michele W. L. Teng
Gabrielle T. Belz
Christian R. Engwerda
Nicholas D. Huntington
Kyohei Nakamura
Michael Hölzel
Mark J. Smyth
Nature Immunology, 2024, 25 : 925 - 926
[4] NK cells and type 1 innate lymphoid cells: partners in host defense
Spits, Hergen
Bernink, Jochem H.
Lanier, Lewis
NATURE IMMUNOLOGY, 2016, 17 (07) : 758 - 764
[5] NK cells and type 1 innate lymphoid cells: partners in host defense
Hergen Spits
Jochem H Bernink
Lewis Lanier
Nature Immunology, 2016, 17 : 758 - 764
[6] T-BET drives the conversion of human type 3 innate lymphoid cells into functional NK cells
Kiekens, Laura
Wahlen, Sigrid
Persyn, Eva
De Vos, Zenzi
Taghon, Tom
Vandekerckhove, Bart
Leclercq, Georges
FRONTIERS IN IMMUNOLOGY, 2022, 13
[7] Natural killer cells and other innate lymphoid cells in cancer (vol 18, pg 671, 2018)
Chiossone, Laura
Dumas, Pierre-Yves
Vienne, Margaux
Vivier, Eric
NATURE REVIEWS IMMUNOLOGY, 2018, 18 (11) : 726 - 726
[8] Conventional NK Cells and Type 1 Innate Lymphoid Cells Do Not Influence Pathogenesis of Experimental Glomerulonephritis
Rickassel, Constantin
Gnirck, Ann-Christin
Shaikh, Nikhat
Adamiak, Virginia
Waterhoelter, Alex
Tanriver, Yakup
Neumann, Katrin
Huber, Tobias B.
Gasteiger, Georg
Panzer, Ulf
Turner, Jan-Eric
JOURNAL OF IMMUNOLOGY, 2022, 208 (07): : 1585 - 1594
[9] Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers
Kang, Jiman
Liggett, Jedson R.
Patil, Digvijay
Ranjit, Suman
Loh, Katrina
Duttargi, Anju
Cui, Yuki
Oza, Kesha
Frank, Brett S.
Kwon, DongHyang
Kallakury, Bhaskar
Robson, Simon C.
Fishbein, Thomas M.
Cui, Wanxing
Khan, Khalid
Kroemer, Alexander
FRONTIERS IN IMMUNOLOGY, 2022, 13
[10] Interplay Between Liver Type 1 Innate Lymphoid Cells and NK Cells Drives the Development of Alcoholic Steatohepatitis
Cheng, Chen
Zhang, Qian
Li, Yue
Jiang, Jiali
Xie, Linxi
Shen, Haiyuan
Wu, Dongqing
Zhang, Hejiao
Zhang, Huiru
Wang, Xuan
Wu, Hongyu
Xu, Jingjing
Gui, Li
Li, Bao
Ju, Cynthia
Peng, Hui
Yin, Shi
Xu, Long
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, 15 (01): : 261 - 274

← 1 2 3 4 5 →